advertisement

---

Wei W 12

Showing records 1 to 12 | Display all abstracts from Wei W

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Li G
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang H
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wang N
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Zhang R
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang Y
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang Y
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wei W
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Chen R; Liu Y
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Lu H
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Li Y
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhai S; Zhang C
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wei W
BMC Ophthalmology 2022; 22: 163

---